Evotec (NASDAQ:EVO) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.24) by 60.42 percent. This is a 46.15 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $208.23 million which missed the analyst consensus estimate of $215.46 million by 3.36 percent. This is a 8.14 percent decrease over sales of $226.69 million the same period last year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。